跳至主要内容
临床试验/NCT05798572
NCT05798572已完成不适用

Is Preoperative Sildosine Adminstration Faciltate Ureteral Diltation During Flexible Ureterorenoscopy?

Benha University1 个研究点 分布在 1 个国家目标入组 140 人开始时间: 2022年3月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
140
试验地点
1
主要终点
Entrance to bladder time (ETBT)

研究概览

简要总结

We proposed that silodosin administration preoperatively may facilitate ureteral access sheath (UAS) placement prior to flexible ureteroscopy (F-URS) and decrease the incidence of ureteric injury in some difficult cases.

详细描述

Urolithiasis is a common urological disorder in the world and has a significant effect on the global health system. The goal of treatment is to achieve the highest stone-free rate (SFR) with the least invasive. Per¬cutaneous nephrolithotomy and flexible ureterorenoscopy (F-URS) are the two main minimally invasive procedures for the treatment of upper urinary tract stones.

The challenging step in flexible ureterorenoscopy (F-URS) is ureteroscopic access sheath (UAS) placement, which facilitates fast and safe access to the ureter and collecting system; improves visibility; reduces the risk of infection by reducing intrarenal pressure. However, in some cases, the acute ureteric injury may occur during ureteroscopic access sheath (UAS) placement.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Upper ureteric stone or stone kidney (with stone burden equal to or less than 20mm).
  • Non stented.
  • Age (Above 18 years old).

排除标准

  • Acute or chronic renal insufficiency.
  • Uncorrected coagulopathy.
  • Previous open (lumber or ureteric) surgery.
  • Active urinary tract infection unless treated.

研究组 & 干预措施

Sildosin group

Experimental

included 70 patients for whom flexible ureteroscopy (F-URS) was done with the daily preoperative intake of 8 mg silodosin for one week.

干预措施: Sildosin group (Drug)

Placebo/control group

Experimental

included 70 patients for whom flexible ureteroscopy (F-URS) was done with daily preoperative intake of placebo tablets.

干预措施: Placebo/control group (Procedure)

结局指标

主要结局

Entrance to bladder time (ETBT)

时间窗: Intraoperatively

Entrance to bladder time (ETBT) will be recorded

次要结局

  • Entrance to ureteric orifice time (ETUOT)(Intraoperatively)
  • Application of access sheath time (AAST)(Intraoperatively)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Tamer Abd El-Wahab Diab

Lecturer of Urology, Faculty of Medicine, Benha University, Benha, Egypt

Benha University

研究点 (1)

Loading locations...

相似试验